共 50 条
- [21] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial Cardiology and Therapy, 2020, 9 : 535 - 540
- [28] Baseline predictors of major adverse events for transthyretin amyloidosis cardiomyopathy patients treated and untreated with disease-modifying therapy AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S87 - S88
- [30] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 98 - 105